Virtual Reality Therapy for Vertigo
(VR-PVD-RCT Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of this treatment for vertigo?
Research shows that virtual reality-based vestibular rehabilitation can significantly improve symptoms in patients with vestibular disorders, making the treatment more enjoyable and potentially more effective than conventional therapy. Additionally, internet-based vestibular rehabilitation has been shown to reduce symptoms of dizziness and vertigo for up to 6 months.12345
Is virtual reality therapy for vertigo safe for humans?
Research on virtual reality therapy for vertigo, including studies on patients with vestibular disorders, suggests that it is generally safe for humans. These studies have not reported significant safety concerns, indicating that virtual reality-based vestibular rehabilitation is a safe option for managing vertigo symptoms.12356
How is the Virtual Reality Therapy for Vertigo treatment different from other treatments for vertigo?
This treatment is unique because it combines standard vestibular rehabilitation with virtual reality technology, allowing patients to perform exercises at home in an engaging and interactive way, which can enhance the rehabilitation process and potentially reduce costs compared to traditional methods.12345
What is the purpose of this trial?
This parallel-group randomized controlled trial aims to determine if the location of the lesion(s) in the vestibular system (unilateral versus bilateral, lateral semi-circular canal versus otolith) impacts the effectiveness of adjunct take-home head-mounted display (HMD) virtual reality (VR) therapy in improving patient symptomatology. Fifty patients meeting inclusion criteria will be recruited from the principal investigator's neurotology clinic. Baseline symptomatology questionnaires will be completed, followed by random allocation to virtual reality and control groups. Vestibular rehabilitation and virtual reality protocols will be adhered to for 4 to 8 weeks, followed by symptomatology questionnaires. Data analysis will be conducted to answer the study's objectives.
Research Team
Desmond A Nunez, MD, MBA
Principal Investigator
Division of Otolaryngology, Department of Surgery, The University of British Columbia
Eligibility Criteria
This trial is for adults over 18 with chronic peripheral vestibular disorders like vertigo or Meniere's Disease, diagnosed using specific tests. They must have had the condition for at least 3 months and be prescribed vestibular rehabilitation. Participants need to have access to a smartphone.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline data collection including symptomatology questionnaires and patient interviews
Treatment
Participants undergo 4 to 8 weeks of vestibular rehabilitation with weekly in-person sessions and daily at-home exercises. The VR group also uses a VR headset for 20 minutes daily.
Follow-up
Participants are monitored for changes in symptomatology and return VR headsets
Treatment Details
Interventions
- Standard Vestibular Rehabilitation with Adjunct At Home Virtual Reality Vestibular Rehabilitation
- Standard Vestibular Rehabilitation with Adjunct Auditory Intervention
Standard Vestibular Rehabilitation with Adjunct At Home Virtual Reality Vestibular Rehabilitation is already approved in United States, European Union for the following indications:
- Vestibular disorders
- Balance problems
- Dizziness
- Vestibular rehabilitation
- Inner ear disorders
- Visual dependence
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of British Columbia
Lead Sponsor